RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Bladder Cancer · Muscle-Invasive Bladder Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Contact: Study coordinator (Peng Xu, doctor) · 18665073650

Study leads

Abai Xu, doctor
Principal Investigator
Zhujiang Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers

Muscle-Invasive Bladder Carcinoma · Bladder Cancer

Abroad (travel likely)Recruiting

Suresnes, France

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

Bladder Cancer · Non-muscle-invasive Bladder Cancer · Muscle-Invasive Bladder Carcinoma

Abroad (travel likely)Recruiting

Charlottesville, United States

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Bladder Adenocarcinoma · Bladder Clear Cell Adenocarcinoma · Bladder Mixed Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Anchorage, United States

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Muscle Invasive Bladder Urothelial Carcinoma · Stage II Bladder Cancer AJCC v8 · Stage IIIA Bladder Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Gilbert, United States